Financhill
Back

Compagnie Financiere Richemont SA Vs. NovoCure Industry Stock Comparison

Sell
37

CFRUY
Compagnie Financiere Richemont SA

Last Price:
14.41
Seasonality Move:
6.19%
Buy
82

NVCR
NovoCure

Last Price:
30.52
Seasonality Move:
2.04%
Sell
37
Compagnie Financiere Richemont SA (CFRUY) is a Sell

Is Compagnie Financiere Richemont SA a Buy, Sell or Hold?

  • The current Compagnie Financiere Richemont SA [CFRUY] share price is $14.41. The Score for CFRUY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CFRUY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
82
NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
  • NVCR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

CFRUY Stock Price Chart

What is Compagnie Financiere Richemont SA's stock price today?

  • The Compagnie Financiere Richemont SA share price today is $14.41
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CFRUY is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.51
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing slight selling pressure.

CFRUY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 59.38 Buy
Chaikin Money Flow: 1451557 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.38 - 14.4) Buy
Bollinger Bands (100): (13.91 - 15.45) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.24 Buy
Relative Strength Index (14 RSI): 84.56 Buy
Chaikin Money Flow: -690353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.69 - 22.01) Buy
Bollinger Bands (100): (15.44 - 20.28) Buy

CFRUY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.75 Buy
20-day SMA: 13.72 Buy
50-day SMA: 14.42 Sell
200-day SMA: 15.02 Sell
8-day EMA: 13.91 Buy
20-day EMA: 13.88 Buy
50-day EMA: 14.22 Buy
200-day EMA: 14.65 Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.45 Buy
20-day SMA: 18.85 Buy
50-day SMA: 17.12 Buy
200-day SMA: 17.34 Buy
8-day EMA: 23.1 Buy
20-day EMA: 19.92 Buy
50-day EMA: 18.23 Buy
200-day EMA: 19.07 Buy

Compagnie Financiere Richemont SA Earnings Growth & CFRUY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.01 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.

Compagnie Financiere Richemont SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):